Article
Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers
16 Dec 2016
Abstract excerpt
Promising targeted therapy and personalized medicine are making molecular profiling of tumours a priority. For colorectal cancer (CRC) patients, international guidelines made RAS (KRAS and NRAS) status a prerequisite for the use of anti-epidermal growth factor receptor agents (anti-EGFR). Daily, new data emerge on the theranostic and prognostic role of molecular biomarkers, which is a strong incentive for a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
